\begin{table}[ht]
\resizebox{\textwidth}{!}{%
\begin{tabular}{|c|c|c|c|c|l}
\cline{1-5}
IhChIKey                    & Number of hits & Drug name           & Clinical trail  & Mechanism of Action                                &  \\ \cline{1-5}
WNEODWDFDXWOLU-QHCPKHFHSA-N & 7              & fenebrutinib        & phase 2         & Bruton's tyrosine kinase (BTK) inhibitor           &  \\ \cline{1-5}
JFOAJUGFHDCBJJ-UHFFFAOYSA-N & 7              & NMS-P715            & preclinical     & protein kinase inhibitor                           &  \\ \cline{1-5}
QHLVBNKYJGBCQJ-UHFFFAOYSA-N & 4              & NMS-1286937         & phase 2         & PLK inhibitor                                      &  \\ \cline{1-5}
FUXVKZWTXQUGMW-FQEVSTJZSA-N & 4              & 9-aminocamptothecin & phase 2         & topoisomerase inhibitor                            &  \\ \cline{1-5}
DKZYXHCYPUVGAF-JCNLHEQBSA-N & 2              & OTS167              & phase 1/phase 2 & maternal embryonic leucine zipper kinase inhibitor &  \\ \cline{1-5}
VYLOOGHLKSNNEK-PIIMJCKOSA-N & 1              & tropifexor          & phase 2         & FXR agonist                                        &  \\ \cline{1-5}
TZKBVRDEOITLRB-UHFFFAOYSA-N & 1              & GZD824              & preclinical     & Bcr-Abl kinase inhibitor                           &  \\ \cline{1-5}
KZSKGLFYQAYZCO-UHFFFAOYSA-N & 1              & cilofexor           & phase 3         & FXR agonist                                        &  \\ \cline{1-5}
\end{tabular}%
}
\caption{Drugs predicted to interact with SARS-COVID-2 interactors} 
    \label{tab:drug-covid-interactors}
\end{table}
IhChIKey Number of hits Drug name Clinical trail Mechanism of Action
WNEODWDFDXWOLU-QHCPKHFHSA-N 7 fenebrutinib phase 2 Bruton’s tyrosine kinase (BTK) inhibitor
JFOAJUGFHDCBJJ-UHFFFAOYSA-N 7 NMS-P715 preclinical protein kinase inhibitor
QHLVBNKYJGBCQJ-UHFFFAOYSA-N 4 NMS-1286937 phase 2 PLK inhibitor
FUXVKZWTXQUGMW-FQEVSTJZSA-N 4 9-aminocamptothecin phase 2 topoisomerase inhibitor
DKZYXHCYPUVGAF-JCNLHEQBSA-N 2 OTS167 phase 1/phase 2 maternal embryonic leucine zipper kinase inhibitor
VYLOOGHLKSNNEK-PIIMJCKOSA-N 1 tropifexor phase 2 FXR agonist
TZKBVRDEOITLRB-UHFFFAOYSA-N 1 GZD824 preclinical Bcr-Abl kinase inhibitor
KZSKGLFYQAYZCO-UHFFFAOYSA-N 1 cilofexor phase 3 FXR agonist